{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T01:30:17Z","timestamp":1794965417470,"version":"4.9.1"},"reference-count":66,"publisher":"SAGE Publications","issue":"1","license":[{"start":{"date-parts":[[2017,11,16]],"date-time":"2017-11-16T00:00:00Z","timestamp":1510790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Therapeutic Advances in Chronic Disease"],"published-print":{"date-parts":[[2018,1]]},"abstract":"<jats:p>Psoriasis is a systemic inflammatory disease associated with numerous comorbidities and a profound impact on patients\u2019 quality of life. While its complex immune pathogenesis is still not fully delineated, current evidence supports a fundamental role of the T-helper-17 (TH-17) pathway and its related interleukin-17 (IL-17) cytokine. Thus, new antipsoriatic therapies have been developed to block this key cytokine and its downstream effects. Secukinumab is a fully humanized, monoclonal anti-IL-17A antibody, and the first in its class to be approved by the US Food and Drug Administration for the treatment of moderate to severe plaque psoriasis. It has also been approved for the treatment of active psoriatic arthritis and ankylosing spondylitis. Its clinical efficacy in plaque psoriasis has been well demonstrated in numerous phase II and III clinical trials. In addition, it has shown superiority in clinical trials to current biologic agents including etanercept and ustekinumab, with a safe adverse event profile. In correlation with excellent skin improvements, secukinumab is also associated with significant improvements in health-related quality of life measures. Thus, secukinumab offers the potential for equal, or improved, therapeutic effects compared with other biologics, and is a valuable addition to our current antipsoriatic armamentarium.<\/jats:p>","DOI":"10.1177\/2040622317738910","type":"journal-article","created":{"date-parts":[[2017,11,16]],"date-time":"2017-11-16T03:01:39Z","timestamp":1510801299000},"page":"5-21","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":151,"title":["Secukinumab: a review of the anti-IL-17A biologic for the treatment of psoriasis"],"prefix":"10.1177","volume":"9","author":[{"given":"Jillian","family":"Frieder","sequence":"first","affiliation":[{"name":"Baylor Scott and White- Division of Dermatology, Dallas, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dario","family":"Kivelevitch","sequence":"additional","affiliation":[{"name":"Baylor Scott and White- Division of Dermatology, Dallas, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Menter","sequence":"additional","affiliation":[{"name":"Baylor Scott and White- Division of Dermatology, 3900 Junius Street, Suite 125, Dallas, TX 75246, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2017,11,16]]},"reference":[{"key":"bibr1-2040622317738910","doi-asserted-by":"publisher","DOI":"10.1111\/ced.12841"},{"key":"bibr2-2040622317738910","first-page":"138","volume":"158","author":"Kirby B","year":"2008","journal-title":"Br J Dermatol"},{"key":"bibr3-2040622317738910","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2010.09941.x"},{"key":"bibr4-2040622317738910","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2006.08.040"},{"key":"bibr5-2040622317738910","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2003.540"},{"key":"bibr6-2040622317738910","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2008.02.039"},{"key":"bibr7-2040622317738910","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2010.11.055"},{"key":"bibr8-2040622317738910","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.143.12.1493"},{"key":"bibr9-2040622317738910","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.12745"},{"key":"bibr10-2040622317738910","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2011.04060.x"},{"key":"bibr11-2040622317738910","doi-asserted-by":"publisher","DOI":"10.3109\/09546634.2011.607425"},{"key":"bibr12-2040622317738910","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2009.59"},{"key":"bibr13-2040622317738910","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jid.5701213"},{"key":"bibr14-2040622317738910","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2009.399"},{"key":"bibr15-2040622317738910","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2013.12.036"},{"key":"bibr16-2040622317738910","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0014108"},{"key":"bibr17-2040622317738910","doi-asserted-by":"publisher","DOI":"10.1002\/path.2667"},{"key":"bibr18-2040622317738910","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1100123"},{"key":"bibr19-2040622317738910","doi-asserted-by":"publisher","DOI":"10.1038\/nri2586"},{"key":"bibr20-2040622317738910","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2004.08.018"},{"key":"bibr21-2040622317738910","first-page":"1092","volume":"159","author":"Nograles KE","year":"2008","journal-title":"Br J Dermatol"},{"key":"bibr22-2040622317738910","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2009.65"},{"key":"bibr23-2040622317738910","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2010.340"},{"key":"bibr24-2040622317738910","doi-asserted-by":"publisher","DOI":"10.1007\/s11596-007-0329-1"},{"key":"bibr25-2040622317738910","doi-asserted-by":"publisher","DOI":"10.1155\/MI.2005.273"},{"key":"bibr26-2040622317738910","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.2009.03704.x"},{"key":"bibr27-2040622317738910","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-012-1229-1"},{"key":"bibr28-2040622317738910","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2012.04.024"},{"key":"bibr29-2040622317738910","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.12110"},{"key":"bibr30-2040622317738910","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1109017"},{"key":"bibr31-2040622317738910","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1109997"},{"key":"bibr32-2040622317738910","unstructured":"Cosentyx. Prescribing information. Switzerland: Novartis Pharmaceutical Corporation, https:\/\/www.pharma.us.novartis.com\/sites\/www.pharma.us.novartis.com\/files\/cosentyx.pdf (2016, accessed 28 Jun 2017)."},{"key":"bibr33-2040622317738910","unstructured":"Novartis Pharmaceuticals Corporation. Advisory committee briefing material for Cosentyx 2014. Switzerland: Novartis Pharmaceuticals Corporation, https:\/\/www.fda.gov\/downloads\/AdvisoryCommittees\/UCM419023.pdf (accessed 28 Jun 2017)."},{"key":"bibr34-2040622317738910","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.12070"},{"key":"bibr35-2040622317738910","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.13348"},{"key":"bibr36-2040622317738910","first-page":"1226","volume":"15","author":"Gottlieb AB","year":"2016","journal-title":"J Drugs Dermatol"},{"key":"bibr37-2040622317738910","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.14073"},{"key":"bibr38-2040622317738910","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1314258"},{"key":"bibr39-2040622317738910","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.13814"},{"key":"bibr40-2040622317738910","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2016.08.008"},{"key":"bibr41-2040622317738910","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2015.04.011"},{"key":"bibr42-2040622317738910","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.13478"},{"key":"bibr43-2040622317738910","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.12359"},{"key":"bibr44-2040622317738910","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.15706."},{"key":"bibr45-2040622317738910","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.12751"},{"key":"bibr46-2040622317738910","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.15656"},{"key":"bibr47-2040622317738910","volume-title":"Paper presented at 73rd AAD Annual Meeting","author":"Griffiths C"},{"key":"bibr48-2040622317738910","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.12668"},{"key":"bibr49-2040622317738910","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.15707."},{"key":"bibr50-2040622317738910","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2016.11.043"},{"key":"bibr51-2040622317738910","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2016.1255306"},{"key":"bibr52-2040622317738910","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.13911"},{"key":"bibr53-2040622317738910","doi-asserted-by":"publisher","DOI":"10.1177\/1060028015626545"},{"key":"bibr54-2040622317738910","first-page":"3156","volume":"8","author":"Xiong HZ","year":"2015","journal-title":"Int J Clin Exp Med"},{"key":"bibr55-2040622317738910","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-202646"},{"key":"bibr56-2040622317738910","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)61134-5"},{"key":"bibr57-2040622317738910","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.160275"},{"key":"bibr58-2040622317738910","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kex301"},{"key":"bibr59-2040622317738910","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2015-209055"},{"key":"bibr60-2040622317738910","doi-asserted-by":"publisher","DOI":"10.1002\/acr.23111"},{"key":"bibr61-2040622317738910","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-eular.1716"},{"key":"bibr62-2040622317738910","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2015.09.004"},{"key":"bibr63-2040622317738910","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2016.07.058"},{"key":"bibr64-2040622317738910","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.13306"},{"key":"bibr65-2040622317738910","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2016.03.024"},{"key":"bibr66-2040622317738910","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2011-301668"}],"container-title":["Therapeutic Advances in Chronic Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/2040622317738910","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/2040622317738910","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/2040622317738910","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T23:17:30Z","timestamp":1777591050000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/2040622317738910"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,16]]},"references-count":66,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["10.1177\/2040622317738910"],"URL":"https:\/\/doi.org\/10.1177\/2040622317738910","relation":{},"ISSN":["2040-6223","2040-6231"],"issn-type":[{"value":"2040-6223","type":"print"},{"value":"2040-6231","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,16]]}}}